Featured Product

    IOSCO Consults on Policy Measures for OTC Leveraged Products

    February 13, 2018

    IOSCO issued a consultation report that proposes policy measures to consider when addressing the risks arising from the offer and sale of OTC leveraged products to retail clients. The report on retail OTC leveraged products identifies various regulatory approaches aimed to enhance the protection of retail investors who are offered OTC leveraged products, often on a cross-border basis. The report covers the offer and sale by intermediaries of rolling-spot forex contracts, contracts for differences (CFDs), and binary options. Comments on the consultation report must be submitted on or before March 27, 2018.

    IOSCO proposes the following policy measures in the report and offers guidance to regulators on how to apply each one:

    • A licensing requirement for all firms that sell the relevant products to retail investors either domestically or on a cross-border basis
    • Leverage limits or minimum margin requirements
    • Measures to address the risk of investors losing more than their initial investment
    • Measures to enhance the disclosure of costs and charges of the products
    • Measures to improve the disclosure of risks of the products, including profit and loss ratios
    • Other focused requirements to enhance the quality of pricing and order execution
    • Measures to restrict the sale, distribution, and marketing of the products with a view to addressing mis-selling risk

    Intermediaries market and sell these products to retail investors in most IOSCO member jurisdictions. In its report, IOSCO encourages its members to improve the practices of licensed firms that offer OTC leveraged products, in an effort to better inform investors about the features and risks of these products and to more effectively combat illegal cross-border activity in this area. This consultation report is part of the ongoing work of IOSCO on retail investor protection. In December 2016, IOSCO had published a fact-finding report titled "Report on the IOSCO Survey on Retail OTC Leveraged Products" that describes the main risks, activities, and participants in this retail OTC market segment. The current consultation is part of a wider IOSCO mandate, which will also include policy proposals and guidance regarding investor education material on relevant products and firms, along with the enforcement approaches and practices to address the risks posed by unlicensed firms operating in this area. IOSCO is seeking feedback on the tools and measures proposed in this report.

     

    Related Links

    Comment Due Date: March 27, 2018

    Keywords: International, Securities, OTC Leveraged Products, Customer Protection, IOSCO

    Related Articles
    News

    ESMA Updates Q&A on Credit Rating Agencies Regulation

    ESMA updated questions and answers (Q&A) document on the Credit Rating Agencies (CRA) Regulation.

    February 17, 2020 WebPage Regulatory News
    News

    EC Announces Funding for Sustainable Finance Project in France

    EC announced an investment for the latest projects, including a project on sustainable finance, under the LIFE program for the environment and climate action.

    February 17, 2020 WebPage Regulatory News
    News

    FDIC Releases Economic Scenarios for Stress Testing in 2020

    FDIC released the hypothetical economic scenarios for use in the upcoming stress tests for covered institutions with total consolidated assets of more than USD 250 billion.

    February 14, 2020 WebPage Regulatory News
    News

    EBA Acknowledges EC Adoption of Amended Supervisory Reporting Standard

    EBA acknowledged the adoption, by EC, of an Implementing Act with regard to the common reporting (COREP) and financial reporting (FINREP) changes, in accordance with the Capital Requirements Regulation or CRR.

    February 14, 2020 WebPage Regulatory News
    News

    APRA and ASIC Welcome Proposed Reforms for Superannuation Sector

    APRA and the Australian Securities and Investments Commission (ASIC) have jointly welcomed the proposed legislative reforms increasing the role of ASIC in the superannuation sector.

    February 14, 2020 WebPage Regulatory News
    News

    ESMA Responds to EC Consultation on Review of Benchmarks Regulation

    ESMA published its response to EC consultation on review of the Benchmarks Regulation in EU.

    February 14, 2020 WebPage Regulatory News
    News

    OSFI on Guide and Form for Replicating Portfolio Information Summary

    OSFI revised the instruction guide and form related to filing the Replicating Portfolio Information Summary.

    February 14, 2020 WebPage Regulatory News
    News

    ISDA Guide on Smart Contracts for Equity and Interest Rate Derivatives

    ISDA has published the fourth and fifth installments in a series of legal guidelines for smart derivatives contracts.

    February 13, 2020 WebPage Regulatory News
    News

    FED Paper Describes FLARE, A Top-Down Model for Stress Testing

    FED published a technical paper that describes the Forward-Looking Analysis of Risk Events (FLARE) model.

    February 13, 2020 WebPage Regulatory News
    News

    EC Rule Updates Data for Calculations Under Solvency II Reporting

    EC published the Implementing Regulation 2020/193, which lays down technical information for the calculation of technical provisions and basic own funds for reporting with reference dates from December 31, 2019 to March 30, 2020, in accordance with the Solvency II Directive (2009/138/EC).

    February 13, 2020 WebPage Regulatory News
    RESULTS 1 - 10 OF 4680